Science to practice contrast agents for imaging tumor angiogenesis: Is bigger better?

Radiology

Volumn 235, Issue 1, 2005, Pages 1-2

  Choyke, Peter L ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; DENDRIMER; GADOLINIUM; NANOPARTICLE;

ANGIOGENESIS; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTRAST ENHANCEMENT; MACROMOLECULE; MOLECULAR WEIGHT; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TUMOR GROWTH; HUMAN; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); NOTE; PATHOLOGY; VASCULARIZATION;

CONTRAST MEDIA; HUMANS; MAGNETIC RESONANCE IMAGING; MOLECULAR WEIGHT; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 15944381597     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2351041773     Document Type: Article

References (4)

1. McDonald DM, Choyke PL. Imaging of angiogenesis: from microscope to clinic. Nat Med 2003; 9:713-725.
2. Morgan B, Thomas AL, Drevs J, et al. Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for the pharmacological response of PTK787/ZK 222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases, in patients with advanced colorectal cancer and liver metastases: results from two phase I studies. J Clin Oncol 2003; 21:3955-3964.
3. Brasch R, Turetschek K. MRI characterization of tumors and grading angiogenesis using macromolecular contrast media: status report. Eur J Radiol 2000; 34:148-155.
4. de Lussanet QG, Langereis S, Beets-Tan RG, et al. Dynamic contrast-enhanced MR imaging kinetic parameters and molecular weight of dendritic contrast agents in tumor angiogenesis in mice. Radiology 2005; 235:65-72.